medigraphic.com
SPANISH

Revista Médica de Costa Rica y Centroamérica

Colegio de Medicos y Cirujanos República de Costa Rica
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2020, Number 630

<< Back Next >>

Rev Med Cos Cen 2020; 86 (630)

Prevalencia y epidemiología de las infecciones bacterianas en pacientes con hepatitis alcoh lica: estudio descriptivo de pacientes hospitalizados en el hospital san rafael de alajuela

Ochoa PA, Coste MP, Moreno AJ
Full text How to cite this article

Language: Spanish
References: 14
Page: 16-26
PDF size: 283.55 Kb.


Key words:

Alcoholic hepatitis, Infection, Mortality, leukocytosis, Acute on chronic liver failure.

ABSTRACT

Introduction and aims: Bacterial infections in patients with alcoholic hepatitis (AH) have a high incidence and can contribute to the development of organ failure and death. The aims of this study were: (1) to determinate the prevalence and epidemiology of bacterial infections in patients with AH; (2) to evaluate the epidemiological and clinical characteristics in patients with AH; (3) to identify predictive factors associated with infections in patients with AH; (4) to determine the proportion of patients with positive microbiological cultures; and (5) to investigate the mortality in patients with AH with and without infection.
Material and methods: this is a retrospective and observational study that included patients admitted to the San Rafael de Alajuela Hospital, Costa Rica; between November 2019 and February 2020. All medical records of patients who met the selection criteria were review.
Results: There were analyzed 41 patients (80% male, mean age: 50 years 10) were analyzed. A high prevalence of concurrent sepsis was observed (73%, 36% nosocomial), with a proportion of culture positivity of 45%, and equivalence between gram-positive and gram-negative microorganisms. Only the presence of leukocytosis and neutrophilia was associated with an increased risk of infection. The model with leucocytes values alone was the best predictive model for the presence of infection. The area under the ROC curve of the presence of leukocytosis was 0.86 (95% CI: 0.73-0.98) and the cut-off was 9520/mm3 presented the best diagnostic accuracy (S: 90%, E: 72.7%). Acute on chronic liver failure (ACLF) and severe AH was associated with high mortality.
Conclusions: The results confirm the high prevalence of bacterial infections in patients with AH. Leukocytes value was a marker related with the development of infection and ACLF was associated with higher mortality.


REFERENCES

  1. Louvet A, Wartel F, Castel H, et al. Infection in patients with severe alcoholic hepatitis treated with steroids: early response to therapy is the key factor. Gastroenterology. 2009 Aug;137(2):541-8

  2. Thursz MR, Richardson P, Allison M, et al. STOPAH Trial. Prednisolone or pentoxifylline for alcoholic hepatitis. N Engl J Med. 2015;372(17):1619-28

  3. Michelena J, Altamirano J, Abraldes JG, et al. Systemic inflammatory response and serum lipopolysaccharide levels predict multiple organ failure and death in alcoholic hepatitis. Hepatology. 2015;62(3):762-72

  4. Dao A, Rangnekar AS. Steroids for Severe Alcoholic Hepatitis: More Risk Than Reward?. Clin Liver Dis. 2019;12(6):151-53.

  5. Crabb D, Im G, Szabo G, et al. Diagnosis and Treatment of Alcohol-Related Liver Diseases: 2019 Practice Guidance from the American Association for the Study of Liver Diseases 2019.

  6. Gustot T, Fernandez J, Szabo G, et al. Sepsis in alcoholrelated liver disease. J Hepatol. 2017;67(5):1031-50

  7. Kumar K, Mohindra S, Raj M, Choudhuri G. Procalcitonin as a marker of sepsis in alcoholic hepatitis. Hepatol Int. 2014;8(3):436-42.

  8. Minuk G, Cohen A, Thompson V. Differences between infected and noninfected patients with acute alcoholic hepatitis. Can J Infect Dis. 1992;3(5):240-2

  9. Singal A and Shah V. Infection in severe alcoholic hepatitis: yet another piece in the puzzle. Editorial Gastroenterology 2017;152(5)930-940.

  10. Teli MR, Day CP, Burt AD, Bennett MK, James OF. Determinants of progression to cirrhosis or fibrosis in pure alcoholic fatty liver. Lancet. 1995;346(8981):987-90

  11. Mueller S, Nahon P, Rausch V, et al. Caspase-cleaved keratin-18 fragments increase during alcohol withdrawal and predict liver-related death in patients with alcoholic liver disease. Hepatology. 2017;66(1):96-107.

  12. European Association for the Study of the Liver. European Association for the Study of the Liver. EASL Clinical Practice Guidelines: Management of alcohol-related liver disease. J Hepatol. 2018;69(1):154-181.

  13. Moreau R, Jalan R, Gines P, et al. Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis. Gastroenterology 2013;144(7):1426-1437.

  14. Moreno C, Deltenre P, Senterre C, et al. Intensive enteral nutrition is ineffective for patients with severe alcoholic hepatitis treated with corticosteroids. Gastroenterology 2016;150(6):903-910.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Med Cos Cen. 2020;86